Breast Cancer

Widespread changes to oncology items proposed by MBS Review Taskforce

The MBS Review Taskforce has released a large number of proposed changes to oncology items in areas such as chemotherapy management, tumour markers and diagnostic imaging. Its reports, released a few days before Christmas, contain recommendations from numerous Taskforce’s clinical committees including medical oncology, pathology and nuclear medicine. Significant changes include an overhaul of existing items ...

Already a member?

Login to keep reading.

© 2021 the limbic